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a  b  s  t  r  a  c  t
Introduction:  Quality  improvement  systems  (QIS)  that are  based  on  empirical  performance
assessment  have  increasingly  been  implemented  as a mandatory  part  of  health  systems
across  countries.  This  study  aims  to describe  national  mandatory  QIS  in Europe  in  2014.
Materials  and  methods:  Relevant  national  agencies  for national  mandatory  QIS  in Europe
were  identiﬁed  through  online  searches  and  key  informants.  A  questionnaire  was  com-
piled during  a  workshop  with  these  agencies  and  ﬁlled  out  by  representatives  from  these
particular  agencies.
Results: Agencies  in  charge  of  national  mandatory  QIS in  seven  countries  (Denmark,  France,
Germany,  Israel,  Scotland,  Sweden  and  Switzerland)  were  included  in  the  study.  An  analysis
of QIS  revealed  similarities,  such  as  the  use  of  routine  data  for performance  assessment  and
the aim  to hold  healthcare  providers  accountable.  Differences  relate  to  the  different  forms
of feedback  systems  and  improvement  mechanisms  used.  Trends  include  the  development
towards  greater  implementation  of QIS within  health  systems,  the inclusion  of  the  patient’s
perspective  in performance  assessment,  and  experiments  with  pay  for performance-related
measures.
Conclusion:  On  a  country  level,  for  health  systems  striving  for newly  implementing  QIS it  is
recommended  to  start  where  routine  data  is available,  add  qualitative  methodologies  once
the  QIS  is getting  more  complex,  report  performance  data  back  to  service  providers  and  be
patient  centred.
∗ Corresponding author at: AQUA—Institute for Applied Quality Improvement and Research in Health Care, Maschmühlenweg 8, Göttingen 37073,
Germany.
E-mail  address: bramesfeld.anke@mh-hannover.de (A. Bramesfeld).
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On  the  inter-country  level exchange  of information  between  agencies  commissioned  with
implementing  national  QIS is very  much  needed  for
1.  Better  understanding  the  other  systems;
2. Gaining  inspiration;
3.  Working  towards  obtaining  better  evidence  on  the  impact  that  the  different  tools  used
and  measures  taken  by  national  QIS  have  on  the  quality  of care  at  health  system  level.
Crown  Copyright  © 2016  Published  by Elsevier  Ireland  Ltd.  This  is  an open  access  article
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. Introduction
Quality improvement systems (QIS) which aim to
ncourage healthcare organisations to improve quality and
erformance [1] and that are based on empirical perfor-
ance assessment, are increasingly being implemented
n a national level as an integral and mandatory part of
 country’s health system [2]. Being based on empirical
erformance assessment means that data is systematically
ollected for indicators on healthcare structures, processes
nd outcomes.
Across Europe and also globally, there is awareness that
he quality of healthcare does not always meet expected
tandards and that inequalities remain in access, delivery
nd outcomes. Value for money and the level of spend-
ng on healthcare is often felt to be unsatisfactory [3].
oreover, the use of empirical performance assessment
lso highlights an increasing demand for transparency and
ccountability in all public processes, including healthcare
o which all citizens are exposed, and which are also vital to
hem. Despite the growing interest in QIS that are based on
ndicators, little is known about the actual status and activ-
ties of national QIS in Europe. While there are numerous
ublications that deal with the challenges of QIS by consid-
ring their contents and conceptions [4,5], hardly anything
as been published on the operational issues arising from
mplementing QIS at national and health system level.
National QIS reﬂect historical developments and tra-
itions of health systems and they consider local
equirements as well as speciﬁc responsibilities in health-
are. These differ in each country [6]. As a result, each
ational QIS is unique and varies by status and measure-
ent [7]. However, the challenges that national QIS face
re often similar: for instance, ﬁnding performance indi-
ators that are meaningful, distinguishing between “good”
nd “poor” quality while being technically implementable,
ommunicating results in a way that is understandable to
ay persons, including patients’ perspectives, and trans-
ating results of performance assessment into quality
anagement. The approach to these and any other chal-
enges may  differ across countries but the purpose of
ational QIS are similar, i.e. to address inequalities in
ealthcare provision by creating external motivation for
ealthcare organisations to change and in doing so achieve
etter performance. Furthermore, what some national QIS
ave in common is that they are mandatory. Mandatory
eans that healthcare providers cannot opt out of provid-
ng data to the QIS. Therefore, data assessment methodsnment  License  (OGL)  (http://www.nationalarchives.gov.uk/doc/
open-government-licence/version/3/).
need to be applicable to all health services in a country
and mandatory QIS need to respect and adhere to regula-
tions and legal constraints of the respective health system
and country. This legal and operational framework is what
distinguishes national and mandatory QIS from voluntary
QIS. It leaves its mark in their governance and how they are
embedded in the respective health system.
Despite the common challenges of national QIS and
despite their aims being similar, there is very little
exchange of information between national QIS. This is even
more relevant as the differences between national QIS
might not only be a result of the different health and legal
systems and traditions, but might also be related to a lack
of evidence regarding the consequences of such different
approaches at national level and the lack of exchange of
experiences between countries [8].
Against this background, the study presented here aims
to explore the status and functioning of QIS in Europe
that are nationwide, use indicators for performance assess-
ment and are mandatory. It describes the practice of these
national mandatory QIS in 2014 from an operational point
of view. The interest lies particularly in documenting the
characteristics of national QIS, in exploring what these
programmes have in common and in which way  they
differ with regard to governance structures, organization
of information systems and regulation of performance
improvement.
2. Materials and methods
2.1. Study design
Online survey with key informants, supported by a
group meeting.
2.2. Sample
Included were agencies in Europe tasked to develop and
implement mandatory, nationwide QIS in healthcare, using
indicators for empirical performance assessment.
Relevant agencies were identiﬁed through the website
of the European Union Network for Patient Safety and
Quality of Care, PaSQ Joint Action, the list of attendees
of the European Commission’s Working Group on Patient
Safety and Quality of Care, the OECD Health Care Quality
Indicators Project, and the 2013 conference of the Inter-
national Society for Quality in Healthcare (ISQua). Once an
agency or individual had been identiﬁed, they were con-
tacted via e-mail to verify that they were indeed operating a
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national QIS by indicators. They were also asked to identify
additional agencies which could be included in the study.
Identiﬁed agencies were invited to a workshop meeting.
Every agency contacted, consented to their participa-
tion and contributed to this paper. The sample included six
European countries and Israel which was selected because
of its strong links with Europe. The respective agencies that
implement nationwide mandatory QIS in healthcare using
indicators included:
• Denmark (DK): Clinical Quality Program of the Regions.
• France (FR): Haute Autorité de Santé (HAS).
• Germany (DE): AQUA—Institute for Applied Quality
Improvement and Research in Health Care GmbH.
• Israel (IL): Israel National Program for Quality Indicators
in Community Healthcare.
• Scotland (SC): Healthcare Improvement Scotland.
• Sweden (SE): National Board of Health and Welfare
(Socialstyrelsen).
• Switzerland (CH): Federal Ofﬁce of Public Health (FOPH,
Bundesamt für Gesundheit).
In April 2014, a two-day workshop with representatives
of all identiﬁed agencies took place in Germany. The aims
of the workshop were to get an overview on practices of QIS
in other health systems and to design an online question-
naire to provide further information on the delivery of QIS
in the seven countries. During the workshop, each country
presented its respective QIS, including scope, history and
working principles.
2.3. Questionnaire
A questionnaire was drafted to assess the practice of the
national QIS systems. The line of questions followed more
or less the natural course of data assessment, analysis and
feedback which is part of the daily work of QIS agencies, but
is also in line with the Plan-Do-Study-Act (PDSA) cycle. The
draft was discussed with all participants at the workshop
Box 1: Proﬁles of national and mandatory quality improv
Denmark
Healthcare system: the Danish healthcare system is public
three administrative levels including the state, regions and mu
at hospital level as well as setting political standards and goa
and outpatient medical care are owned and run by the ﬁve D
rehabilitation, long-term care, health promotion and illness pre
QIS governance: the Danish QIS stemmed from voluntary c
societies. Today, there are more than 60 registries that are ove
the management, ﬁnancing and data protection within the reg
priorities and making decisions on behalf of the clinical registries
regions, medical societies and health authorities. Based on an
regions, the professional boards of the registries are responsib
by the professional societies.
Performance assessment: since QIS is mandated by healt
the registries can take place without patient consent. It is mand
Improvement mechanisms:  results from data collection are
the clinicians and regional management information systems. A
of results and recommendations. All results from indicator asse
Consequences for service providers not achieving the expected 
They range from mandatory naming and shaming providers pu
of the registries or to implementing consequences by applying 120 (2016) 1256–1269
and adjusted accordingly. The ﬁnal questionnaire consisted
of 46 questions that assessed the practice of mandatory
and national performance measurement using indicators
in four domains:
(1) Governance: including the mandate for quality assess-
ment, responsibilities, ﬁnancing and healthcare sectors
covered;
(2) Measurement methodology: including methods and
scope of assessment, as well as data sources used;
(3) Data analysis and interpretation:  including issues such
as reference ranges, assessment of reliability, validity,
discriminative power, indexing;
(4) Improvement mechanisms: including scope and
methodology of reporting data to various audiences
including the public and consequences derived from
assessment results.
The type of questions were either closed multiple choice
questions – such as “Who mandates quality assurance?”,
or open free text questions – such as “For which indica-
tors are outcomes of QIS publicly reported? Please provide
examples”.
The questionnaire was completed after the workshop,
with veriﬁcation and clariﬁcation being sought from par-
ticipants where appropriate. The data was transferred into
tables to enable analysis of responses. The contents of the
tables were processed for presentation in this publication.
The drafts were sent to all participants for veriﬁcation of
the presentation of their own QIS. As such, all participants
are co-authors to this publication.
3. ResultsAll seven agencies ﬁlled out all 47 questions of the ques-
tionnaire. Box 1
presents brief descriptions of the respective QIS in the
seven countries.
ement systems (QIS) using indicators.
, mainly ﬁnanced through taxes and is organized across
nicipalities. The state mainly has a regulatory function
ls for healthcare services nationwide. Danish hospitals
anish regions whilst municipalities are responsible for
vention programmes.
linical registries that were founded by scientiﬁc medical
rseen by regional governments who are responsible for
istries. Legally, the regions have the last word in setting
. This, however, is usually decided in a dialogue between
 agreement between the professional societies and the
le for their own decisions. These boards are appointed
hcare legislation, reporting of person-identifying data to
atory for all healthcare organizations.
 reported monthly in some clinical areas, and quarterly to
 report is released annually with more detailed analysis
ssment are publicly available at unit level on the internet.
quality of care are dealt with by the registries themselves.
blicly at unit level, to coercion by the line management
 certain contractual conditions.
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France
Healthcare system: a public health insurance scheme ensures universal coverage of healthcare to all residents in
France. Healthcare is regulated centrally by the state (Ministry of Health) providing a general governance framework
to regional health agencies (ARS). These are in charge of developing speciﬁc action plans at regional level including
licensing, funding, restructuring services, regulatory inspections, and regional public health plans.
QIS governance: the French QIS is based on the accreditation programme for hospitals. This was legally mandated in
1996. It aims at improving the quality and safety of care by generating sustainable changes in procedures, accountability
and providing information to the public. The programme plays an increasing role within healthcare regulation. It is
conducted by the Haute Autorité de Santé (HAS, the French National Authority for Health), which is a public scientiﬁc
body with ﬁnancial autonomy and is active in various ﬁelds of healthcare quality assurance, including the accreditation
programme for hospitals. The HAS reports to the French parliament and the government.
Performance assessment: since 2008, the accreditation programme has included the mandatory assessment of
indicators for speciﬁc clinical areas. Results of these indicators are included in the accreditation assessment. Accreditation
is renewed every four years, while indicators are assessed every two years.
Improvement mechanisms:  health care services have access to individual and comparative results of national qual-
ity indicators. In addition, they have access to quality data narrowed down by department. Accreditation decisions extend
from full accreditation to accreditation with recommendations, accreditation with reservations, conditional accreditation,
and no accreditation [43]. If the need for improvement is identiﬁed, follow-up measures with the respective health-
care organisation are implemented. Once this has happened, any reservations to the accreditation may  be removed,
maintained or changed.
Germany
Healthcare system: the healthcare system in Germany is mainly ﬁnanced by statutory health insurance companies
which insure about 90% of the population, while the rest are mostly privately insured. The scope of services available to
the population under the statutory health insurance scheme is governed centrally by the Federal Joint Committee (FJC,
Gemeinsamer Bundesausschuss). The FJC is the joint self-governing body of physicians, dentists, hospitals and health
insurance funds.
QIS governance:  the FJC also regulates QIS. It has mandated a private research institute, the AQUA Institute, with
operating the national mandatory QIS. In 2016, this mandate will be passed over to a newly founded public national
institute for quality assessment.
Performance assessment: currently, the QIS evaluates quality exclusively by indicators. These indicators are
assessed annually for 30 clinical areas in all German hospitals that provide the respective care. Depending on the caseload
of the clinical area, data is collected either directly by the AQUA Institute or by the 17 state (Länder) administrative ofﬁces
for quality assurance.
Improvement mechanisms:  consequences for not meeting required quality standards are likewise moderated either
by the AQUA Institute or the state’s administrative ofﬁces for quality assurance. Such consequences can range from a
simple follow-up of quality results, to imposing consequences on healthcare providers.
Israel
Healthcare system: the National Health Insurance Law (1995) ensures that all permanent residents and citizens of
Israel enjoy universal coverage and are entitled to a whole host of beneﬁts and services, including primary care, diagnosis
and treatment, acute hospitalizations, rehabilitation and psychiatric care. The beneﬁts and services are speciﬁed under the
law and updated annually. All citizens are required to enroll in one of the four Health Maintenance Organizations (HMO).
There is a free choice of HMO  and switching is easy. The system is ﬁnanced by taxes, both general and earmarked payroll
tax (health tax) collected by the National Insurance Institute and also from relatively low out-of-pocket co-payments.
QIS governance: the QIS in Israel started as a research project funded by the National Institute for Health Policy
Research (NIHPR) and was adopted as a national quality programme by the Ministry of Health in 2004. The programme
assesses the quality of primary care only, including preventive services, screening, treatment and management of ill-
nesses. The programme is supported by a voluntary partnership of all four Health Maintenance Organizations (HMO)
covering most of the Israeli population. As an academic directorate at the Hebrew University of Jerusalem, it deﬁnes
the indicators and analyses and reports the data.
Performance assessment: quality of care is assessed entirely by electronic data provided by the HMOs from various
sources, including medical and nursing records, pharmacy claims, laboratory results and hospital procedure codes. Data
includes processes and outcome measures.
Improvement mechanisms:  results from the QIS are reported in the public domain as well as to the Ministry of
Health. The HMOs incorporate the results and their position in comparison to other results into their quality improvement
working plans. Further systematic measures for translating assessment results into measures for improvement are not
implemented.
Scotland
Healthcare system: health services in Scotland are ﬁnanced almost entirely from general taxes and are largely
free when needed and are available to all inhabitants. Responsibility for health and for health services rests with the
Scottish Cabinet Secretary for Health, Wellbeing and Cities Strategy who delegates many  of the functions related to
healthcare delivery to 14 integrated territorial National Health Service (NHS) boards. They are responsible for planning
and delivering all health services – acute, primary and community – to the population in their areas. There is strong
accountability to the Scottish Parliament via ministers and through scrutiny by the parliamentary Health Committee,
Audit Scotland and Healthcare Improvement Scotland within a broader National Performance Framework [44].
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QIS governance: the QIS in Scotland is part of the Scottish National Health Service (NHS). NHS boards are accountable
to ministries and the Scottish government for the quality of healthcare that they provide. The Scottish QIS is undertaken
by Healthcare Improvement Scotland (HIS) which has two roles: Assessing services for their quality and supporting them
in improving care. Services covered include long-term care, private psychiatric hospitals, NHS and private hospices, and
prison healthcare as well as regular healthcare.
Performance assessment: HIS scrutinizes NHS and independent services for their quality of care by a range of
methods, including indicators, peer reviews and focus groups.
Improvement mechanisms:  results from the QIS are reported to service providers publicly as well as to the govern-
ment. In case expected quality standards are not met, HIS authors and follows up recommendations and requirements.
Sweden
Healthcare system: health care in Sweden has its overriding goals stipulated in The Health and Medical Services
Act which devolves the responsibility for providing healthcare and public health services to county councils/regions and
municipalities. Health care is predominantly ﬁnanced through regional and local taxes, supplemented by grants from
the national government and patient fees.
QIS governance: QIS is based at the National Board of Health and Welfare (Socialstyrelsen). The Socialstyrelsen is
active in various ﬁelds of quality assurance, licensing, evidence-based medicine, evaluations and it operates several
central registries. These include registries on patients, cause of death, cancer, and prescribing drugs. Publicly funded
healthcare providers have been obliged to send data to these registries since 1968.
Performance assessment: since 2006, data from the Swedish registries has been used for purposes of quality
assessment. The Socialstyrelsen analyzes this data and processes it in cooperation with the Swedish Association of
Local Authorities and Regions. In order to interpret the data, it is enhanced by data that is drawn from voluntary as well
as mandatory registries and from patient surveys.
Improvement mechanisms:  the Socialstyrelsen publishes assessment results in a public report once a year [35].
These public reports include benchmarks of the regions for some indicators. Reports compare services but remain
descriptive. Interpreting the data, drawing conclusions and putting it into action is moderated by the authorities of the
21 Swedish counties which are responsible for the provision of healthcare.
Switzerland
Healthcare system: the Swiss health care system is characterized by a high degree of decentralization. The 26
cantons are responsible for the provision of health care. They are in charge of hospital planning that is based on criteria
deﬁned on a national basis. Coverage has been universal for all citizens since 1996. More than 2/3 of acute inpatient
care is provided by public hospitals and publicly subsidized hospitals. The funding of the hospital system is distributed
between mandatory healthcare insurance and cantonal subsidies.
QIS governance: the federal QIS in Switzerland is based at the Federal Ofﬁce for Public Health (FOPH).
Performance assessment: the FOPH assesses quality by indicators once a year for all Swiss hospitals that provide
acute care. Quality indicators are derived from the Initiative for Quality in Medical Care (IQM, Initiative Qualitätsmedizin),
an initiative set up by several private and public hospital owners in Germany for measuring and improving the quality
of inpatient care.
Improvement mechanisms:  the FOPH publishes caseload and mortality rates annually for 41 different classes of
diagnoses/interventions for all hospitals that provide acute care. The data is made available to the public on a website
that allows a comparison by indicators of up to three hospitals. The FOPH does not interpret the results from indica-
e the tor assessment but sends them to the cantons which us
management depending on individual canton policy.
3.1. Governance
All of the mandatory QIS were established at the begin-
ning of the 21st century. That said, Sweden was far ahead in
terms of data collection and made the submission of data to
patients’ registries mandatory as early as 1968. However,
data from these registries has only been used for quality
assessment purposes since 2006. An overview on gover-
nance and scope of the QIS in the respective countries is
provided in Table 1.
3.1.1. Mandate for quality assessment
QIS are mandated in most countries by central govern-
ment, e.g. the national ministry of health or parliament.
However, in countries with statutory health insurance
it is also the health insurance companies that mandate
QIS. In Israel, the QIS is mandated by the National Insti-
tute for Health Policy Research in conjunction with the
country’s four Health Maintenance Organizations (HMOs)
which are broadly responsible for healthcare nationwide.results for information, healthcare planning and quality
In Germany, a joint self-governing body of healthcare
providers and health insurance companies, the Federal
Joint Committee, mandates the implementation of the QIS.
In Denmark, the mandate for the QIS is jointly provided
by parliament and professional societies. The professional
societies that once set the basis for QIS by implement-
ing registries, consider these registries not only a measure
of performance benchmarks but also a source of research
data.
In the majority of countries, the mandate for operating
QIS is devolved to a public agency. This can be an institution
embedded within a public body such as a ministry (Scot-
land, France, Switzerland). In two  countries, universities
play a major role in QIS: In Israel an academic directorate,
which is based at the Hebrew University of Jerusalem, has
been commissioned with conducting the national QIS and
in Denmark more than 60 registries are served by three
university departments specialized in clinical epidemiol-
ogy. A third option is to mandate a private, independent
institution with the execution of a QIS. This was the case
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Table 1
Governance structure and scope of national quality improvement systems (QIS) in European healthcare.
CH DE DK FR SC SE IL
Initial year of national mandatory QIS 2008 2004 2003 2008 NHS Scotland is
expected to
comply, however it
is not mandatory
2006
Use of mandatory
registries for
QIS + voluntary
registers which
service providers
are expected to
comply with
2004
Body  that mandates QIS Ministry of Health Federal Joint
Committee
Parliament,
professional
societies
Ministry of Health
and Haute Autorité
de Santé (HAS)
Scottish
government Health
Directorate and
Cabinet Secretary
for Scotland
Ministry of Health,
National Board of
Health and
Welfare, the
county councils
The National
Institute for Health
Policy Research
jointly with the
four Health
Maintenance
Organizations
(HMO) (i.e.
sickness funds) of
Israel
Purpose  of QIS
Clinical quality improvement
√ √ √ √ √ √ √
Choice,  trust, voice (public reporting)
√ √ √ √ √ √
Management of services
√ √ √ √
Inspection (safety, regulatory)
√ √ √
Health  system governance
√ √ √ √ √
Contracting
√
Sectors covered by national QIS
Hospital care
√ √ √ √ √ √
Mental healthcare
√ √ √ √ √
Outpatient care
√ √ √ √ √ √
(primary care)
Social  care
√
Long-term care
√ √ √ √
Integrated care
√ √ √
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in Germany were the QIS was mandated (after being put
to tender) to the AQUA Institute, a private entity. How-
ever, in 2016 this mandate will be transferred to a public
institution.
3.1.2. Mandate for sanctions
A speciﬁc mandate for healthcare inspections, including
sanctions on healthcare providers and recommendations
for improvements if quality standards are not met, is part
of the QIS in Denmark, Germany, France and Scotland. In
Switzerland and Sweden, the mandate is limited to pro-
viding information on the quality of care to the public, but
above all to the cantons and counties. However, processing
this information and putting it into action is the regional
responsibility of the cantons and counties.
3.1.3. Sectors covered by QIS
QIS in two  countries assess the quality in only one sec-
tor: Switzerland’s QIS is at the moment restricted to acute
hospital care (indicators are being developed for home
care and long-term care) and Israel’s to primary care only.
However, recently a new programme was established by
the Ministry of Health to also assess quality of care in
Israeli hospitals. Denmark, Germany, France and Sweden,
besides assessing the quality of inpatient care for all clinical
areas, also assess outpatient care in at least some clini-
cal areas. Sweden provides the most comprehensive QIS
that covers hospital care, outpatient care, mental health-
care, social care, long-term care and integrated care. In
Switzerland, the Association Nationale pour le développe-
ment de la Qualité dans les hôpitaux et les cliniques (ANQ,
www.anq.ch), a joint organization of cantons, healthcare
providers and insurance associations, publishes quality
indicators (e.g. surgical site infection rates, pressure ulcers)
which compliment the quality indicators published by the
Federal Ofﬁce of Public Health.
3.1.4. Purpose
Beyond the aim of improving the quality of clinical care,
in all countries QIS seeks to provide transparent informa-
tion on the quality of healthcare to the public. Further
objectives of national QIS include offering citizens the pos-
sibility to choose their healthcare provider on the basis
of information on quality, increasing trust in healthcare
institutions through greater transparency and also giving
patients’ priorities a voice. All systems except the Israeli
system include public reporting as a core aim. The core
aim of the Israeli programme is to provide information on
healthcare quality at national level to all stake holders for
the purpose of healthcare improvement and for policy and
planning. Public reporting by the HMOs has become a more
central issue in recent years.
3.2. Measurement methodology
3.2.1. Instruments
Since it was an inclusion criterion, QIS in all the coun-tries studied use indicators for measuring the quality of
care (see Table 2). In France, this is supplemented by site
visits in the context of accreditation. In Scotland, a range
of guidance is used, and qualitative as well as quantitative 120 (2016) 1256–1269
standards are applied. In addition, public and staff engage-
ment is monitored to explore speciﬁc issues related to the
quality of care. Thus, indicators are just one method among
others in Scotland for collecting information on the qual-
ity of care. Denmark, like France and Scotland, also relies
on a number of parallel and only partly coordinated QIS
approaches in addition to indicator assessment, such as
patient satisfaction surveys and peer reviews in the con-
text of a mandatory national accreditation system. This is
different to Germany, Israel and Sweden, which base their
QIS almost exclusively on indicators.
3.2.2. Frequency of assessment
Most countries publish indicators annually. In France,
indicators are assessed biannually and accreditation is car-
ried out every four years. In Scotland, the frequency of
reporting varies according to the indicators, and can occur
before the end of a year or indeed after a 12-month period.
3.2.3. Data sources
General data sources for QIS include electronically
available routine data, extra documentation by health-
care providers and patient surveys. Table 2 provides an
overview of the data sources each country uses. All coun-
tries use electronically available routine data (Switzerland
and Israel exclusively), while the others also (or mainly, as
is the case in Germany) collect data through additional doc-
umentation made available by healthcare providers. QIS
in four countries, Denmark, France, Scotland and Sweden,
have also implemented patient surveys and feedback as
part of the regular quality assessment procedure; Germany
is currently in the process of planning such a patient sur-
vey. These patient surveys are used mostly for assessing
indicators on process and outcome.
In addition, qualitative methodologies are used in
France and Scotland for collecting data on structures, pro-
cesses and outcomes. In France, this comprises site visits in
connection with the accreditation process, and in Scotland
it comprises a multitude of methodologies. Follow-ups are
measured in Germany, Israel and Sweden. France is cur-
rently drawing up follow-up assessment procedures.
3.3. Data analysis and interpretation
3.3.1. Data analysis
Usually reference ranges or standards are used for indi-
cator analysis. Sweden mainly uses standards if available,
otherwise data is presented as relative comparisons.
All countries except France apply risk adjustment to
their data analysis, at least for the factors age and gen-
der. Israel additionally uses socioeconomic status for
risk adjustment, whereas Sweden uses Diagnosis Related
Groups (DRGs), Germany a multitude of factors applied by
logistic regression, and Scotland various methods of risk
adjustment depending on the subject.
3.3.2. Data interpretation
There are various modes for interpreting the results
of indicator assessment. Israel interprets its data based
on the average collected by healthcare providers, as
does Denmark (including standard deviation). Results
A
.
 Bram
esfeld
 et
 al.
 /
 H
ealth
 Policy
 120
 (2016)
 1256–1269
 
1263
Table 2
Methodologies used for assessing quality of care.
CH DE DK FR SC SE IL
Assessment by indicators
√ √ √ √ √ √ √
Assessment  by other methods Site visits in the context
of  accreditation
Variety of qualitative
methods
Focus  of assessment
Quality of speciﬁc diseases or therapeutic
interventions (clinical areas)
√ √ √ √ √ √ √
General  quality (indicators)
√ √ √
Quality  of interventions for prevention and
screening
√
Prevention and screening Prevention and screening Prevention and
screening
Data  source for assessing structures
Manual/extra documentation
√ √ √ √ √
Electronic  systems at provider level
√ √ √ √ √
Data  at cost carrier level
√
Patient survey
√ √
Other  methodology Groupings of
hospitals within the
medical statistics
The accreditation process Methodologies look at
culture, leadership,
values, behaviour which
support quality
Data  source for assessing processes
Manual/extra documentation
√ √ √ √ √
Electronic  systems at provider level
√ √ √ √ √ √
Data  at cost carrier level
√ √
Patient survey
√ √
Other  The accreditation process Methodology is tailored
to  service/area being
scrutinized
Data  source for assessing outcome
Manual/extra documentation
√ √ √ √ √
Electronic  systems at provider level
√ √ √ √ √ √ √
Data  at cost carrier level
√
Patient survey
√ √ √ √
Other  Review of
documentation,
interviews with patients,
carers, public, staff
Periodic research to
assess additional
outcomes
Data  source for assessing follow-up
Not  measured
√
Manual/extra documentation
√ √ √
(not measured
currently)
√
Electronic  systems at provider level
√ √
(not measured for
now)
√ √
Claims  data
√
Patient survey
√
(not measured for
now)
√
Other  Follow-up visits review
action plans put in place
as  a result of scrutiny
activities
Follow-up of
indicators is
conducted in the
following year
Data  source for assessing quality of indication √ √ √
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in Germany are interpreted using the average and the
worst-performing hospital, whereas in France they are
interpreted in relation to the best, the average and the
worst healthcare provider. Scotland’s data is reported both
comparatively (between regional health providers) and
relatively (such as an individual healthcare provider’s per-
formance over time). Switzerland and Sweden do not have
a particular focus for interpreting their data. Data is pro-
vided as a service to the cantons/counties and it is up to
them as to how they interpret it and use it. Denmark has a
special arrangement in the clinical registries whereby the
professional boards generally are obliged to formulate tar-
gets for improvement in relation to every indicator. This is
done based on available evidence and practical experience
of the professional board, and is documented in special
reports.
3.4. Improvement mechanisms
Improvement mechanisms include how results from
quality assessment are reported and to whom, as well as
resulting sanctions and measures. An overview is provided
in Table 3.
3.4.1. Level of presenting data
The countries usually present their data on several lev-
els of aggregation: Single provider/service level, regional
and country level. The level of the single provider/service is
used by all countries. All but Switzerland and Israel present
their data also on a regional level. In the case of Germany,
the regional level is represented by the federal states which
range in size from 1 million to 12 million inhabitants. With
the exception of Switzerland, each country also presents
its QIS data on an aggregated country level. As do other
countries, Switzerland uses the OECD Healthcare Quality
Indicators for benchmarking at a national level.
3.4.2. Data reporting
There are numerous audiences for the published data,
such as the authorities at regional and country level, includ-
ing policy makers and cost bearers, academics and policy
makers, and ﬁnally the general public.
All countries report the performance directly back to
the service providers. Furthermore, data is reported to the
ministries of health in Denmark, France, Israel, Scotland
and Sweden. They are reported also to the cost bear-
ers of the individual healthcare systems, which, in Israel,
France and Germany, are the health insurance compa-
nies (in Germany, the data is reported to the Federal Joint
Committee which includes the health insurance compa-
nies). In Scotland, healthcare is funded by the National
Health Service and in Denmark and Sweden by the regional
governments to which results of performance measure-
ment are reported. In Switzerland, results are reported to
the cantons which are responsible for healthcare provi-
sion.
A benchmark of services is made available to the public
in France, Sweden and Denmark where it can be reviewed
on a website hosted by the regions. In Sweden, there are
two sorts of benchmark reports that are available: One is
a descriptive “open comparison” of the hospital at regional 120 (2016) 1256–1269
and national level; the other reports on the compliance
of services with guideline recommendations. In Germany,
hospitals are publicly benchmarked for survival rates of
premature neonates. However, participation in this bench-
mark procedure is currently voluntary.
3.4.3. Sanctions, measures and actions
In Denmark and Scotland, healthcare providers that
are not performing well are required to present an action
plan for improvement. In Denmark, this action plan needs
to be approved by the central regional management and
often by the political council. For highly specialized ser-
vices, such as cancer care, authorization to provide this
form of care can be withdrawn by the national health
board. In Germany, healthcare services that do not meet
the expected quality standards are subject to a “structured
dialogue”. This means that healthcare providers have to
justify the data that lies outside deﬁned reference ranges,
and in case of quality deﬁcits, they need to present strate-
gies for improvement. In France, if indicators show that the
required quality standards have not been met, this may
result in consequences affecting an accreditation decision.
In Israel, Sweden and Switzerland, there are no deﬁned
consequences for performing below expectations. Conse-
quences in Sweden and Switzerland may  be imposed by the
counties/cantons as they are responsible for their health-
care.
3.4.4. Follow-up of improvement
Measures that are taken to bring about improvement
to low performing services are systematically surveyed
in all countries, however in Switzerland, only if a can-
ton decides to do so. In France, the HAS follows up
healthcare providers that are required to improve their
service quality. In Israel, this is done by the Chief Med-
ical Ofﬁcers of the four HMOs who  are responsible for
QIS. In Scotland, improvement support is available from
Healthcare Improvement Scotland (which is the same orga-
nization that undertakes healthcare scrutiny). In Germany,
healthcare providers that are required to improve their
services are followed up either centrally by the AQUA
Institute or by one of 17 administrative ofﬁces for qual-
ity assurance at regional level. In Sweden, the central
public agency responsible for QIS (Socialstyrelsen) fol-
lows up with the county councils on their activities
to bring about improvement. In Denmark, follow-up is
done by a hospital’s line management and at regional
level. In some cases, scientiﬁc societies (gynaecology,
orthopaedic surgery, cardiology) have follow-up proce-
dures.
Financial consequences linked to performance of ser-
vices are implemented in Denmark and Sweden. However,
in Denmark pay-related performance has been tried only
in two regions; in one of the regions, it has already been
discontinued and the other region only reserves 2% of
its budget for it. In Sweden, ﬁnancial incentives exist in
some counties and are linked to some indicators. Also,
central government has linked indicators to incentives in
certain speciﬁc areas. There is a continuous debate on
the beneﬁts and drawbacks of this practice in Sweden. In
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Table 3
Reporting of data and sanctions.
CH DE DK FR SC SE IL
Level at which results of QIS are presented
Service level
√ √ √ √ √ √ √
Country level
√ √ √ √ √ √
Regional level
√ √ √ √ √
Public benchmark of results
√ √
Addressee of QIS results
Healthcare providers or hospitals
√ √ √ √ √ √ √
Ministry of health
√ √ √ √ √
Public
√ √ √ √ √ √ √
other Federal Joint
Committee
Regional
management
Consequences if quality standards
are not met
None; it is up to
cantons to
implement
consequences
Structured
dialogue
An action plan has
to be presented.
Worst case:
authorization is
withdrawn
Accreditation
decision
Recommendations
and requirements
Consequences are
implemented by
the counties if they
wish
None
Financial implication of not
performing well
None None Two regions
experiment with
P4P (10% of
hospital budget
withheld until
standards are met)
Piloting ﬁnancial
incentive approach
Action taken by
some counties
None
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France, a ﬁnancial incentive approach is currently being
piloted.
4. Discussion
National QIS hold a unique position in their respec-
tive health systems. However, this means that there is no
means within a country to compare or exchange infor-
mation on technical and operational issues. As there are
particular technical issues that arise from implementing
QIS on a national level, it follows that countries can beneﬁt
from mutual exchange and can learn from other national
QIS [9]. Exchanging information with other countries, and
thus, having the opportunity to learn from each other,
is, however, hindered not only by a general unawareness
of QIS in other countries (see Section 4.7) but also by
a signiﬁcant language barrier. National QIS usually pub-
lish their policies, methodologies and results primarily in
their own language and as grey literature [10–15]. Also,
the differences in health systems add to the complexity of
understanding other national QIS.
This study brought together and compared seven
indicator-based national QIS from across Europe and Israel.
All of these national programmes were set up after the year
2000, indicating that QIS using indicators is a somewhat
new and emerging ﬁeld. In the last 15 years, there has gen-
erally been an increased interest in QIS, in particular for
QIS using indicators and for peer reviews and accredita-
tion [16]. Also, policies are becoming increasingly popular
that promote the implementation of QIS which is also seen
as a strategy to strengthen a country’s health system [16].
However, this also highlights the fact that neither the mar-
ket, nor self-regulations or voluntary efforts are sufﬁcient
to improve the quality of care provided in complex health
systems [17].
Despite all countries being unique in their approach on
how to assess the quality of healthcare, the study revealed
considerable similarities between national QIS. These simi-
larities could be used as an orientation for countries aiming
to newly implement, restructure or expand their QIS.
4.1. Sectors covered
QIS usually start in one sector and then expand [8].
The more consequently a national QIS is implemented,
the broader the scope is of the areas that it covers. This
means that these QIS do not only assess the quality of care
in respect to speciﬁc disorders, but also include preven-
tion, screening and general healthcare quality indicators
that cover a whole variety of healthcare options as rec-
ommended by the Council of Europe [18]. Contrary to
illness-speciﬁc indicators, general indicators are used to
either provide a measure for the quality of a health sys-
tem as such, and thus, to determine policy and planning [8]
(this, for example, is the main mandate of the Israeli QIS,
operating by general indicators only) or, general indicators
are used to measure general procedures within primary
prevention, such as the Israeli QIS which assesses whether
an adult should be weighed once a year by a general prac-
titioner. 120 (2016) 1256–1269
Most QIS have started operating by focusing on hospital
care; however, the example of Israel shows that QIS can also
originate from outpatient care focusing on a medical spe-
cialisation (primary care) instead of a speciﬁc intervention
or illness. QIS that are currently active in only one sector
(e.g. Switzerland, Israel, Germany) are aiming to expand to
other sectors. With this in mind, it remains a challenge to
all QIS to not only measure performance in different sec-
tors, but also cross-sectorally. Some of the most relevant
challenges to healthcare performance arise when patients
cross sectors: [18] crossing sectors is inevitable, in partic-
ular when considering ever shorter hospital stays and a
shift towards outpatient care. This is particularly relevant
when treating chronic illnesses where patients may  need
care from different providers and medical specialities. This
presents a challenge to the continuity of care in terms of
information, management and patient-provider relation-
ship [19]. Consequently, providing continuity of care has
been deﬁned as one major aspect of quality of care in health
systems [20,21].
4.2. Routine data
Electronically available routine data seems to be the
backbone of national QIS [22]. All QIS examined here use
routine data at some point; some use them exclusively such
as the Israeli and the Swiss systems. However, much data
is assessed alongside additional documentation. Not only
does this triangulated approach increase reliability, it also
overcomes some of the challenges of single-use data, for
example much of the data is collected to support reim-
bursement. The disadvantage of additionally documented
data relates to it adding to the burden of documentation
and to it being more susceptible to manipulation than
routine data [23]. By having already implemented a well-
functioning system for data assessment in general health
monitoring, this facilitates the setting up of a national QIS
[8,24].
Despite a number of similarities, there are also many dif-
ferences between the countries’ QIS. This is partially due to
differences in national policies and legislations, but might,
however, also be due to a lack of consensus and experi-
ence on how to best implement quality measurement and
improvement measures. One of the striking differences is
the way consequences are drawn from performance assess-
ment. In the relatively centralised health systems of, for
example, France or Germany, the agencies operating the
QIS have the power to hold a health care provider account-
able. In strongly regionally organised health systems such
as the Swedish or Swiss health system, this is left to local
institutions; it is the agency’s role primarily to provide data.
There is no knowledge as to whether this impacts on the
effectiveness of QIS in terms of improving the quality of
healthcare.
Further areas where QIS differ include:
4.3. Qualitative methodologyOnly Scotland and France use qualitative methodolo-
gies in addition to quantitative indicators (focus groups,
site visits within accreditation) for performance assess-
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ent. Germany is planning to do so in the context of
eer assessments [25]. While quantitative indicators have
he advantage of representing quality in a reliable and
omparable way, they have the disadvantage of usually
eing surrogates of procedures that are normally much
ore complex. Indicators disregard relevant issues that
re outside their scope, such as patient–therapist inter-
ction, and that might be difﬁcult to measure [23]. In
ddition, “indicators only indicate” [8], they also need to be
nterpreted. Qualitative assessment methodology adds an
ndividual and an explanatory aspect to quantitative indi-
ators. By that, they value the diversity and complexity of
are procedures and bring them closer to improvement
echanisms [26]. In addition, qualitative methods may
elp to understand and validate quantitative indicators. As
uch, enhancing quantitative indicator-based performance
easurement with qualitative information seems to be a
ecommendable approach.
.4. Patient centredness
The inclusion of patients’ perspectives in performance
easurement, as recommended by the Council of Europe, is
resent in those QIS that are more complex in the sense that
hey use different data sources and assess more than one
ector (Denmark, France, Scotland, and Sweden). It is rec-
mmended that the patient’s perspective also be included
s many relevant outcomes such as pain, satisfaction or
xperience can only be assessed by asking the patient [27].
n addition, patients are often the only link between health-
are sectors and can thus provide information on relevant
are issues, such as use of informal care that are outside
he scope of the respective QIS [28]. However, it needs to
e acknowledged that it is somewhat challenging both in
espect of methodology, legal and data protection issues
o implement meaningful patient surveys within QIS [29].
hus, assessing the patient perspective would probably not
e the ﬁrst thing to be implemented in a newly developed
IS. However, being patient orientated also includes mak-
ng the results of performance assessment available to the
ublic and to potential patients in a way that can be under-
tood by lay persons. Whether and how a QIS succeeds in
his, is not known.
.5. Improvement mechanisms
Direct feedback on performance assessment to the
ealthcare provider, comparison of the single provider to
he mean of all the others and communicating aggregated
esults to the public are improvement tools that are used
y all QIS analysed. These tools have been proven to be
ffective in studies [30–33]. However, what follows after
eporting the data and to what degree the central agency
mplementing the QIS is mandated with executive powers
n holding healthcare providers accountable, differs. Mech-
nisms at all possible levels of regulation in QIS are used
n each of the countries: self-regulation and voluntarism,
s might be stimulated by public benchmarking (“name
nd shame”), meta-regulation, such as mandated improve-
ent, and command and control which could include
ithdrawal of accreditations [17]. While some countries 120 (2016) 1256–1269 1267
use several mechanisms starting with “name and shame”
through public benchmarking to withdrawing authoriza-
tion (Denmark), others use only public reporting (Israel) or
have no deﬁned consequences at all for mal-performance
(Switzerland). In Sweden and Switzerland respectively,
regional bodies are responsible for deﬁning and executing
consequences. Pay for performance is not a regular part of
QIS in any of the countries included in this study. However,
most QIS have run trials on pay for performance in limited
areas.
It needs to be acknowledged that the choice of conse-
quences linked to performance measurement is the result
of a political process. This might explain the differences
found in the QIS studied. While there is evidence on the
effectiveness of linking performance measurement to feed-
back and recommendations for improving quality of care
in general [33], it is not clear which of the strategies for
improvement is the most effective at national level QIS.
Countries seem to differ in their conviction as to how rig-
orous they need to be in this respect [24]. However, in order
to further develop QIS, it would be of necessary to explore
in more depth, if at all possible, which additional effects can
be expected from more rigorous consequences compared
to just “naming and shaming”.
4.6. Impact of QIS
Longitudinally, a general improvement on indicators is
observed in all QIS with regard to both mean indicator
values and the range of indicator values across services
[32,34–37]. Improvements in process indicators might be
interpreted as a sign that healthcare performance has in
fact changed. Whether this impacts on patient outcomes,
needs to be shown by respective outcome indicators. How-
ever, the relationship between processes and outcomes is
not only always evident as such. Moreover it may  also be
blurred by the fact that improvements in process indica-
tors might also be caused by better documentation of data.
The question as to whether changes in performance and
related outcome would have happened without a QIS will
always leave room for debate. However, despite acknowl-
edging that the direct impact of QIS on the quality of care
is ambiguously to prove, we see QIS data shedding light on
healthcare performance quality where prior this was not
known [38,39], as well as conﬁrming guideline adherence
[40] and reducing variability in healthcare performance
across services and regions [35]. In addition, all represen-
tatives from QIS agencies involved in the network reported
that the level of attention paid by clinicians and the pub-
lic to their quality reports had been rising over the years,
indicating an increased sensitivity of both healthcare pro-
fessionals and the general public towards the quality of
performance of health services. Thus, it is no longer a ques-
tion of whether implementing a national QIS in general is
advisable, but more so, as to how a national QIS should
be designed efﬁciently so that the least additional effort
for data collection can be combined with the most useful
assessment outcome in terms of information and promot-
ing quality improvement. This in fact is the challenge that
all QIS implementing agencies face and where exchange
and networking is needed.
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4.7. Limitations
This study focuses on countries in Europe and Israel
as these were the countries meeting the inclusion crite-
ria (national QIS using indicators situated in Europe and
related countries) and that could be identiﬁed with the
methods described. Experiences from other continents and
countries such as Canada, the USA or Australia were not
included even though including them might have changed
the results. Further, QIS in Europe that use indicators such
as the national outcome evaluation programme in Italy
[41], were not included in the network as they could not
be identiﬁed as meeting inclusion criteria by the meth-
ods described. This means that the necessary information
was not available on the agencies’ websites in any of the
languages available to the authors, nor was it possible to
identify any publications on the programme in English. In
addition, none of the participants within the network had
speciﬁc knowledge of the programme. This highlights both
the need for networking among national agencies running
indicator-based QIS to get to know each other better and
for spreading information on these programmes in inter-
national literature. Also, the QIS in England could not be
included. Despite repeated efforts, we could not identify a
central institution in charge of the English QIS. Had we  been
able to include more countries in the study, this might have
changed the results of this analysis. On the other hand, the
network set out to start an exchange about QIS on a prac-
tical working basis, thus the inclusion of seven countries
was considered to be a good starting point in a ﬁeld where
no networking on this level exists at all.
Trying to compare QIS in seven countries might be a
bit like comparing apples and pears as health systems and
their QIS are indeed complex. However, all systems are
striving for the same objective: the improvement of qual-
ity in healthcare. It should, however, not be ignored that
some of the terminology used when discussing QIS might
be understood differently across countries and health sys-
tems. Having said that, having met  in person and discussed
the national QIS at a two day workshop where the ques-
tionnaire was also drafted, and having sent it back and forth
between group members, this might have actually lowered
the risk of misunderstanding.
5. Conclusions
On a country level and based on the ﬁndings of this ini-
tial assessment of QIS in Europe and Israel, policy makers
that plan to embark on implementing national QIS would
be advised to start in a sector where routine data is available
and then gradually expand. As many QIS start performance
measurement by using indicators only, this seems to be a
doable approach. However, once a QIS is becoming more
complex it is advisable to add also qualitative assessment
methodologies as they add an explanatory dimension and
are closer linked to improvement measures. Implementing
feedback mechanisms that report performance data back to
healthcare facilities, including a benchmark to the average,
is central to a QIS; however, there is no supporting evidence
to recommend the implementation of speciﬁc rigorous
methodologies to hold healthcare providers accountable. 120 (2016) 1256–1269
Finally, having QIS being patient centred should be self-
evident nowadays.
On the inter-country level transparency and bench-
marking of QIS within Europe and in particular EU member
states, becomes highly relevant when considering the EU
directive on the application of patients’ rights in cross-
border healthcare. The directive strengthens national QIS in
the sense that information on quality of healthcare needs to
be available also to individuals from other member states
(thus being available also to a country’s own citizens). In
this context, an exchange between agencies commissioned
with implementing national QIS adds value not only on
a technical level, but also at EU level [42]. In addition to
inspiring others, such an exchange adds to the possibility
of
• Getting to know, better understanding and appraising
QIS from other countries;
• Exchanging and sharing information gathered on techni-
cal issues;
• Finding a common language to address issues of perfor-
mance measurement and quality improvement;
• Striving towards a common understanding of quality of
care assessment, including indicator identiﬁcation, data
assessment and analysis, as well as recommendations to
policy makers and healthcare providers;
• Being able to provide better information on the quality of
healthcare not only to a country’s own  citizens, but also
to those from other EU member states;
• Working towards obtaining better evidence for the effec-
tiveness of performance improvement mechanisms at
health system level.
In summary, it needs to be acknowledged that little is
known about the impact that the different tools used and
measures taken by national QIS have on the quality of care
at health system level. As a considerable amount of tax pay-
ers’ money is spent on national QIS, research in this respect
is very much needed. This research needs to be based on an
exchange between countries and health systems [8,42].
Conﬂict of interest
All authors state that they have no conﬂict of interest.
Acknowledgements
We are grateful to Niek Klazinga from the OECD, Björn
Broge, Günther Heller, Tonia Kazmeier, Jürgen Pauletzki
and Gerald Willms, all from the AQUA Institute, for their
contributions to the workshop in 2014 and for their sup-
port in this study. We  are particularly grateful to Sharon
Janicki for revising the English language.
References[1] Care; ISfQiH. International principles for healthcare standards.
Dublin: ISQUA; 2007.
[2] Groene O, Skau JK, Frolich A. An international review of projects on
hospital performance assessment. International Journal for Quality
in  Health Care 2008;20:162–71.
lth Policy
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
ing accreditation decisions from a reduced dataset of focus priorityA. Bramesfeld et al. / Hea
[3] Institute of Medicine. Crossing the quality chasm. A new health sys-
tem for the 21st century. Washington, D.C: National Academy Press;
2001.
[4] Arah OA, Klazinga NS, Delnoij DM,  ten Asbroek AH, Custers T. Con-
ceptual frameworks for health systems performance: a quest for
effectiveness, quality, and improvement. International Journal for
Quality in Health Care 2003;15:377–98.
[5] Arah OA, Westert GP, Hurst J, Klazinga NS. A conceptual framework
for the OECD Health Care Quality Indicators Project. International
Journal for Quality in Health Care 2006;18(Suppl. 1):5–13.
[6] Klazinga N. Re-engineering trust: the adoption and adaption of four
models for external quality assurance of health care services in west-
ern European health care systems. International Journal for Quality
in  Health Care 2000;12:183–9.
[7] Groenewegen PP. Analyzing European health systems: Europe
as  a research laboratory. European Journal of Public Health
2013;23:185–6.
[8] European Commission. So what? Strategies across Europe to assess
quality of care. Report by the Expert Group on Health Systems Per-
formance Assessment. Luxembourg; 2016.
[9] van den Berg MJ,  Kringos DS, Marks LK, Klazinga NS. The Dutch Health
Care Performance Report: seven years of health care performance
assessment in the Netherlands. Health Research Policy and Systems
2014;12:1.
10] HAS. Outils, Guides & Méthodes. Haute Autorité de Santé,
Available at: http://www.has-sante.fr/portail/jcms/fc 1249605/
en/outils-guides-methodes [accessed 14.01.14].
11] NIHP. Quality measures program. The Israel National
Institute for Health Policy Research, Available at:
http://www.israelhpr.org.il/e/87/67.htm [accessed 14.01.14].
12] Socialstyrelsen. Bilaga 2. Täckningsgradsjämförelser mellan hälso-
dataregistren vid Socialstyrelsen och Nationella Kvalitetsregister.
Stockholm: Sveriges Kommuner och Landsting; 2010.
13] Socialstyrelsen. Handbok för utveckling av indikatorer—för
god vard och omsorg. Sammanfattning, Available at:
http://www.socialstyrelsen.se/publikationer2014/2014-7-3;
2014 [accessed 14.01.14].
14] Healthcare Improvement Scotland. Evidence,
advice, guidance and standards, Available at:
http://www.healthcareimprovementscotland.org/evidence.aspx
[accessed 14.01.14].
15] BAG. Forschung im BAG. Bundesamt für Gesundheit, Schweiz-
erische Eidgenossenschaft, Available at: http://www.bag.admin.ch/
themen/gesundheitspolitik/00388/00390/index.html?lang=de
[accessed 14.01.14].
16] Shaw CD, Braithwaite J, Moldovan M,  Nicklin W,  Grgic I, Fortune
T,  et al. Proﬁling health-care accreditation organizations: an inter-
national survey. International Journal for Quality in Health Care
2013;25:222–31.
17] Braithwaite J, Healy J, Dwan K. The governance of health safety and
quality. A discussion paper. Commonwealth of Australia; 2005.
18] Szecsenyi J, Broge B, Eckhardt J, Heller G, Kaufmann-Kolle P, Wensing
M.  Tearing down walls: opening the border between hospital and
ambulatory care for quality improvement in Germany. International
Journal for Quality in Health Care 2012;24:101–4.
19] Haggerty J, Reid R, Freeman G, Starﬁeld B, Adair C, McKendry R. Con-
tinuity of care: a multidisciplinary review. BMJ  2003;327:1219–21.
20] Wierdsma AI, van der Schee M,  Mulder CL. Breakdown of continuity
in  public mental healthcare in the Netherlands: a longitudinal case
study. International Journal of Integrated Care 2011;11.
21] Hofmarcher M,  Oxley H, Rusticelli E. Improving health system per-
formance through better care coordination. Paris: OECD; 2007.
22] CoE. Recommendation No. R (97) 17 of the Committee of Ministers to
member states on the development and implementation of quality
improvement systems (QIS) in health care. (Adopted by the Com-
mittee of Ministers on 30 September 1997 at the 602nd meeting of
the  Ministers’ Deputies). Council of Europe, Committee of Ministers;
1997.
23] Busse R, Nimptsch U, Mansky T. Measuring, monitoring, and man-
aging quality in Germany’s hospitals. Health Affairs (Millwood)
2009;28:w294–304.
24] Bramesfeld A, Amaddeo F, Caldas-de-Almeida J, Cardoso G,
Depaigne-Loth A, Derenne R, et al. Monitoring mental healthcare on
a  system level: country proﬁles and status from EU countries. Health
Policy 2016;120:706–17.
[ 120 (2016) 1256–1269 1269
25] AQUA. Arthroskopie am Kniegelenk. Indikatorenset 1.1 (Stand: 14.
Juli 2014). Göttingen: AQUA—Institut für angewandte Qualitäts-
förderung und Forschung im Gesundheitswesen; 2014. p. 2014.
26] Pope C, van Royen P, Baker R. Qualitative methods in research
on  healthcare quality. Quality and Safety in Health Care
2002;11:148–52.
27] Donabedian A. The Lichﬁeld lecture. Quality assurance in health care:
consumers’ role. Quality in Health Care 1992;1:247–51.
28] Ludt S, Heise F, Glassen K, Noest S, Klingenberg A, Szec-
senyi J. Die Patientenperspektive jenseits ambulant-stationärer
Sektorengrenzen—was ist Patientinnen und Patienten in der sek-
torenübergreifenden Versorgung wichtig? Gesundheitswesen 2013.
29] Bramesfeld A, Pauletzki J, Behrenz L, Szecsenyi J, Willms G,
Broge B. Developing cross-sectoral quality assurance for cataract
surgery in the statutory quality assurance program of the German
health care system: experiences and lessons learned. Health Policy
2015;119:1017–22.
30] Larsson S, Lawyer P, Garellick G, Lindahl B, Lundström M.  Use of 13
disease registries in 5 countries demonstrates the potential to use
outcome data to improve health care’s value. Health Affairs (Mill-
wood) 2012;31:220–7.
31] Torjesen I. National audit shows improvements in hospital care of
hip fracture patients. BMJ  2011;343:d4468.
32] Bridgewater B, Grayson AD, Brooks N, Grotte G, Fabri BM,  Au J, et al.
Has the publication of cardiac surgery outcome data been associ-
ated with changes in practice in northwest England: an analysis of
25,730 patients undergoing CABG surgery under 30 surgeons over
eight years. Heart 2007;93:744–8.
33] Hysong SJ. Meta-analysis: audit and feedback features impact effec-
tiveness on care quality. Medical Care 2009;47:356–63.
34] AQUA. German hospital quality report 2012. Göttingen:
AQUA—Institute for Applied Quality Improvement and Research in
Health Care GmbH; 2014.
35] SALAR, Socialstyrelsen. Quality and efﬁciency in Swedish health
care. Regional comparisons. Stockholm: Swedish Association of Local
Authorities and Regions, Swedish National Board of Health and Wel-
fare; 2012.
36] Jaffe DH, Shmueli A, Ben-Yehuda A, Paltiel O, Calderon R, Cohen AD,
et al. Community healthcare in Israel: quality indicators 2007–2009.
Israel Journal of Health Policy Research 2012;1:2045–4015.
37] Schiele F, Capuano F, Loirat P, Desplanques-Leperre A, Derumeaux G,
Thebaut JF, et al. Hospital case volume and appropriate prescriptions
at hospital discharge after acute myocardial infarction: a nation-
wide assessment. Circulation Cardiovascular Quality and Outcomes
2013;6:50–7.
38] Strauss R, Ewig S, Richter K, Konig T, Heller G, Bauer TT. The prog-
nostic signiﬁcance of respiratory rate in patients with pneumonia:
a retrospective analysis of data from 705,928 hospitalized patients
in Germany from 2010–2012. Deutsches Arzteblatt International
2014;111:503–8.
39] Eggebrecht H, Bestehorn M,  Haude M,  Schmermund A, Bestehorn
K, Voigtlander T, et al. Outcomes of transfemoral transcatheter aor-
tic valve implantation at hospitals with and without on-site cardiac
surgery department: insights from the prospective German aor-
tic  valve replacement quality assurance registry (AQUA) in 17 919
patients. European Heart Journal 2016;37:2240–8.
40] Koster C, Heller G, Wrede S, Konig T, Handstein S, Szecsenyi J. Case
numbers and process quality in breast surgery in Germany: a ret-
rospective analysis of over 150,000 patients from 2013 to 2014.
Deutsches Arzteblatt International 2015;112:585–92.
41] Agenas. National Outcome Evaluation Program—PNE. Agen-
zia  Nazionale per i Servizi Sanitari Regionali, Available at:
http://95.110.213.190/PNEed14 EN/index.php [accessed 17.07.15].
42] Groene O, Klazinga N, Walshe K, Cucic C, Shaw CD, Sunol R. Learning
from MARQuIS: future direction of quality and safety in hospi-
tal  care in the European Union. Quality and Safety in Health Care
2009;18(Suppl. 1):i69–74.
43] Guérin S, Le Pogam MA,  Robillard B, Le Vaillant M,  Lucet B, Gardel
C,  et al. Can we simplify the hospital accreditation process? Predict-standards and quality indicators: results of predictive modelling. BMJ
Open 2013;3:e003289.
44] Steel D, Cylus J. United Kingdom (Scotland): health system review.
Health Systems in Transition 2012;14:1–150.
